At Novo Nordisk, we aspire to write the future of cell
Our focus positions us to pioneer treatments that may be uniquely qualified to change the lives of people living with serious chronic diseases. We are working to develop treatments for Parkinson's disease, chronic heart failure and type 1 diabetes that have the potential to halt disease progression — or even reverse it.
By collaborating with the best in the world, we aim to accelerate the research that’s needed to develop transformative cell therapies faster for those living with serious chronic diseases. We are driving change to shape a future where people may be propelled by aspirations rather than limited by disease.
With every day and every breakthrough, we could come closer to achieving this, together.